News
1don MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Hosted on MSN2mon
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The primary efficacy was to demonstrate the vaccine efficacy against COVID-19 starting 14 days after mNEXSPIKE compared with Spikevax, Moderna's updated COVID-19 vaccine approved on Sept. 6, ...
Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.
Kennedy Jr. canceled nearly half a billion dollars’ worth of grants and contracts for mRNA-vaccine research.With Kennedy leading HHS, this about-face is easy to parse as yet another anti-vaccine move.
1don MSN
Trump previously called mRNA vaccines a 'medical miracle.' Now, RFK Jr. cut $500M in funding
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results